Researchers at Kumamoto University have discovered a monoclonal antibody capable of neutralizing a wide range of SARS-CoV-2 variants, including the elusive omicron subvariants. This antibody, named K4-66, was isolated from a delta breakthrough infection case.This […]
A one-size-fits-all approach for scheduling COVID-19 booster shots may not be the most effective, according to a new study by researchers at the Yale School of Public Health (YSPH) and University of North Carolina at […]
A study of 700 people who tested positive for influenza suggests that their risk of infecting household contacts was 18.8% and that the estimated effectiveness of flu vaccines against secondary infections is 21.0%.This post was […]
Researchers at Leiden University Medical Center and Radboud University Medical Center in the Netherlands have demonstrated promising safety and efficacy of a late-liver-stage attenuated malaria parasite vaccine in a small clinical trial.This post was originally […]
Malaria, particularly in its severe forms, remains a global health and economic burden. It causes the deaths of more than 600,000 people every year—most of them African children under five.This post was originally published on […]
In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like symptoms. But in infants and seniors, these viruses can cause severe pneumonia and even death.This post […]
As whooping cough cases rise in the U.S., a new nasal vaccine developed by Tulane University may hold the key to reducing the spread of the highly contagious respiratory disease.This post was originally published on […]
An electronic letter, or nudge, highlighting the cardiovascular benefits of influenza vaccines improved vaccination rates among more than 2 million adults—with a greater impact on those who have had a heart attack—across three clinical trials […]
mRNA vaccines saved lives during the COVID-19 pandemic, but older people had less of an immune response to the vaccines than did younger adults. Why? Boston Children’s researchers, led by Byron Brook, Ph.D., and Ofer […]
An experimental vaccine has shown promise in protecting against the sexually transmitted disease chlamydia, researchers report.This post was originally published on this site
© 2024 EarnWithSocial.ca - Canada's Technology News and Highlights | Read. Learn. Share.